Loss of Mef2D function enhances TLR induced IL-10 production in macrophages by Pattison, Michael J. et al.
                                                                    
University of Dundee
Loss of Mef2D function enhances TLR induced IL-10 production in macrophages
Pattison, Michael J.; Naik, Rangeetha Jayaprakash; Reyskens, Kathleen M. S. E.; Arthur, J.
Simon C.
Published in:
Bioscience Reports
DOI:
10.1042/BSR20201859
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Pattison, M. J., Naik, R. J., Reyskens, K. M. S. E., & Arthur, J. S. C. (2020). Loss of Mef2D function enhances
TLR induced IL-10 production in macrophages. Bioscience Reports, 40(8), 1-15. [BSR20201859].
https://doi.org/10.1042/BSR20201859
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 04. Sep. 2020
Bioscience Reports (2020) 40 BSR20201859
https://doi.org/10.1042/BSR20201859
*These authors contributed
equally to this work.
Received: 02 June 2020
Revised: 27 July 2020
Accepted: 29 July 2020
Accepted Manuscript online:
29 July 2020
Version of Record published:
21 August 2020
Research Article
Loss of Mef2D function enhances TLR induced IL-10
production in macrophages
Michael J. Pattison*, Rangeetha Jayaprakash Naik*, Kathleen M.S.E. Reyskens and J. Simon C. Arthur
Division of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of Dundee, Dow St, Dundee, DD5 1EH, U.K.
Correspondence: J. Simon C. Arthur (j.s.c.arthur@dundee.ac.uk)
Mef2 transcription factors comprise a family of four different isoforms that regulate a num-
ber of processes including neuronal and muscle development. While roles for Mef2C and
Mef2D have been described in B-cell development their role in immunity has not been ex-
tensively studied. In innate immune cells such as macrophages, TLRs drive the produc-
tion of both pro- and anti-inflammatory cytokines. IL-10 is an important anti-inflammatory
cytokine produced by macrophages and it establishes an autocrine feedback loop to in-
hibit pro-inflammatory cytokine production. We show here that macrophages from Mef2D
knockout mice have elevated levels of IL-10 mRNA induction compared with wild-type cells
following LPS stimulation. The secretion of IL-10 was also higher from Mef2D knockout
macrophages and this correlated to a reduction in the secretion of TNF, IL-6 and IL-12p40.
The use of an IL-10 neutralising antibody showed that this reduction in pro-inflammatory
cytokine production in the Mef2D knockouts was IL-10 dependent. As the IL-10 promoter
has previously been reported to contain a potential binding site for Mef2D, it is possible that
the binding of other Mef2 isoforms in the absence of Mef2D may result in a higher activa-
tion of the IL-10 gene. Further studies with compound Mef2 isoforms would be required
to address this. We also show that Mef2D is highly expressed in the thymus, but that loss
of Mef2D does not affect thymic T-cell development or the production of IFNγ from CD8 T
cells.
Introduction
Toll-like receptors (TLRs) are an important group of receptors that allow the innate immune system to
recognise invading pathogens. TLRs bind to pathogen associated molecular patterns (PAMPs), typically
nucleic acids or cell wall components of the pathogen. TLRs are expressed on a range of immune cell types,
including innate immune cells, such asmacrophages and dendritic cells. Once TLRs bind their appropriate
PAMP, they activate the immune cell and stimulate cytokine production via a core set of signalling path-
ways. All TLRs, with the exception of TLR3, activate intracellular signalling via theMyd88 adaptor protein
which couples TLRs to theMAPK and IKK–NFκB signalling pathways. TLR3 acts via the Trif adaptor and
stimulates Tbk1–IRF3 signalling in addition to MAPKs and NFκB, while TLR4 can act via both Myd88
and Trif (reviewed in [1–4]). In macrophages, a major output from TLR signalling is the production of
pro-inflammatory cytokines such as TNF, IL-6 and IL-12. In addition to their pro-inflammatory effects,
TLRs can also activate anti-inflammatory pathways that are required to prevent excessive inflammation
that may be deleterious to the host. These mechanisms include both negative feedback loops in intra-
cellular signalling and also the production of anti-inflammatory cytokines, of which IL-10 is an example
[5–7]. IL-10, which is produced by macrophages, dendritic cells and subsets of B cells in response to TLR
agonists, is able to inhibit pro-inflammatory cytokine production by macrophages [8,9]. The importance
of this feedback loop is demonstrated by the finding that mice with a conditional deletion of IL-10 in
macrophages are sensitised to endotoxic shock driven by the TLR4 agonist LPS [10] while total loss of
IL-10 function results in sensitisation to colitis in both mice [11] and people [12].
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Much of the research on how TLRs induce cytokine production has centred on roles for NFκB, IRF and MAPK
signalling [1–4]. The transcription factors that act downstream of MAPKs in these pathways however are not fully
elucidated. Mef2 transcription factors comprise a group of 4 proteins, Mef2A, B, C and D, in mammalian cells which
have been identified as potential targets of multiple MAPKs [13]. For example, p38 has been shown to phosphory-
late and activate Mef2A and C [14–16] while ERK5 phosphorylates and activates Mef2A, C and D [17–19]. They
comprise of an N terminal MADS box and MEF domain which are required for DNA binding and dimerization,
and a C-terminal TAD (transcriptional activation domain) [13,20]. In mammalian cells, Mef2 form either homod-
imers or heterodimers with a 2nd Mef2 isoform and the resulting dimers bind to a (C/T)TA(A/T)4TA(A/G) consensus
sequence in DNA [13,21].
Mef2 transcription factors havewell documented roles in development, particularly inmuscle, cardiovascular, bone
and neuronal development [13,22–25]. Mouse knockout of Mef2C results in embryonic lethality, in part due to de-
fects in cardiovascular development [25]. Mef2A knockout results in perinatal lethality due to cardiovascular defects
[26] while Mef2D knockout mice are viable with no overt development phenotype with the exception of a defect in
photoreceptor cell development in the eye [27–29]. The ability of Mef2 to act as heterodimers and the similar consen-
sus sequence recognised by the different isoforms suggests that the different isoformswill have overlapping functions.
In line with this, compound knockouts have revealed more severe phenotypes in several systems including neuronal
development and skeletal muscle regeneration [22,30]. The role of Mef2 in innate immune responses has not been
extensively studied. Loss of Mef2C function early in hematopoietic development causes a block at the common lym-
phoid progenitors (CLP) stage, resulting in greatly reduced numbers of T, B and NK cells but increased numbers
of myeloid cells [31]. Deletion of Mef2C specifically in B cells using CD19-Cre did not impair B-cell development
indicating that once past the CLP stage of development Mef2C is not essential for B cell development. Mef2C was
however required for BCR induced B-cell proliferation and T-cell dependent antibody responses [32,33]. In contrast
with BCR regulated responses, Mef2C was not required for TLR or CD40 induced B-cell proliferation [33]. Com-
pensation between Mef2C and Mef2D occurs in B-cell development as deletion of both isoforms together results in
a block in B-cell development [34].
With the exception of B cells, the specific roles of Mef2D have not been characterized in detail within other cells
of the immune system. We show here that loss of Mef2D does not have a major impact on macrophage, T- or B-cell
development. Macrophages from Mef2D knock out mice however showed a decrease in pro-inflammatory cytokine
production. This was due to an increased production of IL-10.
Methods
Generation of Mef2D knockout mice
To generate Mef2D knockout mice, a targeting vector was constructed as shown in the schematic in Figure 1. To gen-
erate the vector, the arms of homology were PCR amplified from a BAC containing theMef2D gene and sequenced to
ensure they contained no PCR generated mutations. Fragments were then assembled by restriction enzyme cloning
into the final vector. A neomycin resistant cassette lacking a polyadenylation sequence [35] but linked to the splice
donor site from exon3 of the Mef2D gene was included to allow positive selection in ES cells and a thymidine kinase
cassette added for negative selection. The vector was introduced into mouse E14 ES cells by electroporation and ES
cell colonies isolated as described [36]. Targeted ES cells were identified by RT-PCR for the neomycin resistant splices
onto the 3′ region of Mef2D. ES cells were used to generate chimeric mice via blastocyst injection. Surgery to im-
plant blastocysts in pseudo-pregnant females was carried out under aesthesia with a mix of ketamine and xylazine.
Germline transmission was identified by coat colour and confirmed by PCR on ear biopsies. To remove the neomycin
resistance gene mice were crossed to Flpe transgenic mice. To generate the total knockout, mice were crossed to a
Bal1-Cre (Tg(Nes-cre)1Wme, [37]) that resulted in Mef2D deletion in the germline. The resulting heterozygous mice
were backcrossed onto C5Bl/6 mice for 12 generations. Routine genotyping of the mice was carried out by PCR of
ear biopsies used for identification of individual mice using the primers CTCAATATGTTCTCACTTAGGAGCCTC,
TCCCCAAATTGCAACAATATTGGCTATAG and AGACCACCTGCCTAAAGTCACATG which, when used to-
gether, would give a 304 bp band for a wild-type allele and 240 bp band for a knockout allele.
Wild type C57Bl6J mice for backcrossing were obtained fromCharles River Laboratories U.K. Animals were main-
tained under specific pathogen-free conditions in line with EU and U.K. regulations. Nonbreeding mice were housed
in same-sex groups, in individually ventilated sterile cages and had free access to water and food (standard diet R&M1
or R&M3 from SDS Special Diets Services). Animals were maintained in rooms with controlled 12-h/12-h light/dark
cycle, 21 ◦C temperature, and relative humidity of 45–65%.Mice were culled using a raising concentration of CO2 for
5 min and death confirmed via cervical dislocation. All the work was performed at the University of Dundee under a
2 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1. Generation of Mef2D knockout mice
The Mef2d knockout was generated using the strategy shown in panel (A). A targeting vector was used to insert loxP sites upstream
of Mef2D and in intron 2 via homologous recombination in ES cells. Targeted ES cells were used to generate mice carrying the
targeted locus, which were then crossed to mice expressing Flpe to remove the neomycin resistance cassette and then Cre to
delete exons 1 and 2 in the Mef2D gene, as described in the ´Materials and Methods’. To confirm the knockout was successful,
protein extracts from the thymus, spleen, liver, lymph node, hippocampus, cortex and cerebellum of wild type and Mef2D knockout
mice were immunoblotted for Mef2D (B). Levels of p38α MAPK were also determined to confirm equal loading of sample between
the wild-type and Mef2D knockout lysates. ns indicates a non-specific band.
U.K. Home Office project license (70/7901) in accordance with U.K. and EU regulations and approved by local ethi-
cal review by the University of Dundee Ethical Review Committee. Mice were used for isolation of tissue at 10 to 14
weeks of age.
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Flow cytometry
Thymi and spleens were removed and disaggregated in RPMI media. Spleens were treated with RBC lysis buffer
(Sigma). Single cell suspensions, diluted in PBS, were used to analyse total cell counts on BD FACSVerse™ (BD
Biosciences). For phenotyping, cells were washed with FACS buffer (1% BSA in PBS) and Fc γ receptors were
blocked with Mouse BD Fc Block (BD Pharmingen) for 15 min at 4◦C. Cell surface markers on thymocytes
were then stained with anti-Thy1.2-APC, anti-CD4-PE, anti-CD8-BV421 and anti-TCRβ-FITC in FACS buffer
for 20 min at 4◦C. T and B cells in the spleen were stained with anti-TCRβ-FITC, anti-CD4-PE, anti-CD8-APC
and anti-CD19-PerCP-Cy5.5. Myeloid cells in the spleen were stained with anti-F4/80-BV421, anti-CD11b-PE,
anti-CD11c-APC and anti-Gr-1-PerCP-Cy5.5, while FITC was used as dump channel for anti-TCRβ and anti-CD19.
Antibodies used were from BD Biosciences or BioLegend. Stained cells were washed and resuspended in FACS buffer
and acquired on BD FACSCanto™ II (BD Biosciences) using FACSDiva software. Analysis was done on FlowJo.
Expansion of CD8 T cells and measurement of T cell IFNγ production
Spleens were removed, disaggregated in RPMI media and treated with RBC lysis buffer (Sigma). Single cell suspen-
sions were adjusted to 2.5× 106 cells/ml in T-cell media (RPMI-1640 supplemented with 10% heat inactivated FBS, 4
mM L-glutamine, 10 mMHEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μM non-essential amino acids,
1 mM sodium pyruvate and 50 μM 2-mercaptoethanol). Cells were stimulated with 0.5 μg/ml of soluble anti-CD3
monoclonal antibody (145.2C11) and 20 ng/ml IL-2 for 36 h. Cells were then washed, counted and cultured at 1 ×
106 cells/ml in T-cell media containing 20 ng/ml IL-2 every day for 7 days. On day 7, cells were washed and resus-
pended at 0.5 × 106 cells/ml in T-cell media containing 20 ng/ml IL-2. They were then either left unstimulated or
stimulated with anti-CD3 (1 μg/ml) and anti-CD28 (0.5 μg/ml) or Phorbol 12, 13-Dibutyrate (PDBu; 20 ng/ml) and
ionomycin (0.5 μg/ml) for 4 h. Levels of interferon γ were measured in the media by ELISA (eBioscience) according
to manufacturer’s protocol.
Culture of bone marrow derived macrophages
Bonemarrowderivedmacrophages (BMDMs)were cultured as described [38]. Briefly, bonemarrowwas flushed from
the femurs of one mouse using PBS. Cells were then pelleted by centrifugation and cultured on bacterial grade plastic
for 7 days in BMDMmedia (DMEM supplemented with 10% heat inactivated fetal bovine serum, 2mML-glutamine,
100 units/ml penicillin G, 100μg/ml streptomycin, 0.25μg/ml amphotericin and 5 ng/ml recombinantM-CSF). Cells
were then detached by scraping in versene (Invitrogen) and re-plated on tissue culture plastic in BMDMmedia. Cells
were stimulated with 100 ng/ml LPS (E. coli O26:B6, Sigma L2654).
Immunoblotting
For immunoblotting, cells were lysed in 50 mMTris-HCl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 1 mM sodium ortho-
vanadate, 50 mM sodium fluoride, 1 mM sodium pyrophosphate, 10 mM sodium glycerophosphate, 0.27 M sucrose,
1% (vol/vol) Triton X-100, 0.1% (vol/vol) 2-mercaptoethanol and complete proteinase inhibitor cocktail (Roche).
Lysates were clarified by centrifugation (13,000 rpm for 10 min at 4◦C) and supernatants snap-frozen and stored
at −80◦C. Protein concentration was determined with Coomassie Protein Assay Reagent (Thermo Scientific). Pro-
teins were separated on 10% polyacrylamide gels and immunoblotting carried out using standard techniques. An-
tibodies against Mef2D phospho-Thr180/Tyr182 p38, total p38, phospho-Thr202/Tyr204 ERK1/2, total ERK1/2,
phospho-Ser133 CREB, phospho S376 MSK1 and phosphor Ser933 p105 were from Cell Signaling. The antibody
raised against total MSK1 was described previously [39]. Secondary antibodies conjugated to horseradish peroxidase
and bands visualized via Clarity ECL (Bio-Rad) using either film or a Li-Cor Odyssey Fc scanner.
qPCR
Total RNA was prepared from cells using Qiagen RNeasy kits in accordance with the manufacturer’s protocol. RNA
was reverse transcribed using iScript (Bio-Rad). qPCR was carried out using SYBR green based reagents (Takara).
mRNA induction was determined relative to unstimulated wild-type cells as described [40,41]. GAPDH and/or 18S
levels were used to normalise for differences in total RNA concentrations. Primer sequences have been described
previously [40,41].
Determination of cytokine levels
IL-10, TNF, IL-6 and IL-12p40 were measured using a Luminex based assay (Bio-plex, Bio-Rad) according to the
manufacturer’s protocol.
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Results
Generation of Mef2D knockouts
To generate the Mef2D knockout, conventional gene targeting techniques were used to place loxP sites upstream of
exon 2 and downstream of exon 3, as indicated in the schematic in Figure 1A. Initially heterozygous mice were bred
to transgenic mice expressing a Flpe transgene in order to remove the neomycin resistance gene. To generate a total
Mef2D knockout, the Mef2D floxed mice were bred to a germline Cre transgenic mouse to delete exons 2 and 3.
This removes the first 86 amino acids of Mef2D including the MADS box that is required for dimerization and DNA
binding. The resulting heterozygous Mef2Dmice were bred away from the Flpe and Cre transgenes and then crossed
to generate the homozygous knockout. The homozygous knockout mice were viable and born at close to the expected
frequency from heterozygous matings (28%, n=54). The mice had no apparent gross abnormalities and were fertile.
To confirm the knockout resulted in a loss of Mef2D protein, immunoblotting was used to detect Mef2D in lysates
from the thymus, spleen, liver and brain. In wild-typemice levels ofMef2Dwere highest in the thymus, hippocampus,
cortex and cerebellum with lower levels in the lymph nodes and spleen. Mef2d was not detected in the liver. Mef2D
was not detected in lysates from the knockout mice (Figure 1B).
Mef2D is not essential for T-cell development
AsMef2Dwas high in the thymus, we examinedwhether the loss ofMef2Dhad amajor impact onT-cell development.
Thymi and spleens were isolated and immune cell subsets determined by flow cytometry. Cell number in the thymus
was similar between wild-type and Mef2D knockout animals (Figure 2A). In the thymus T cells pass through several
developmental stages, defined by their expression of CD4 and CD8; initially T cells express neither CD4 or CD8
(DN or double negative cells) before up-regulating the expression of both CD4 and CD8 (DP or double positive
cells). Finally, the cells lose expression of either CD4 or CD8 to give single positive (SP) cells which then exit the
thymus [42,43]. The percentage of DN, DP and CD4 SP cells was similar between wild-type and Mef2D knockouts,
although there was a minor increase in the percentage of CD8 SP cells in the Mef2D knockout (Figure 2B). Analysis
of splenocytes following red blood cell lysis showed similar numbers of cells in the Mef2D knockout and wild-type
mice spleens (Figure 2C). Staining for CD19 (B cells) and TCR (T cells) showed that the percentages of both T and
B cells was slightly lower in the Mef2D knocklout mice (Figure 2D). When corrected for the total cell number, this
difference was maintained (4.63 × 107 and 1.94 × 107 for T and B cells respectively in wild-type spleens vs 3.3 × 107
and 1.48 × 107 in Mef2D knockouts); however, the difference was no longer significant (P>0.05, Student’s t-test).
Analysis of CD4 and CD8 within the T-cell population showed no difference between the ratio of CD4 and CD8
T cells between wild-type and Mef2D knockout spleens (Figure 2E). Stimulation of splenocytes with a combination
of anti-CD3 and anti-CD28 to trigger the TCR followed by maintenance in IL-2 resulted in a similar expansion of
cytotoxic T cells from the splenocytes of wild-type and Mef2D KO (Figure 2F). On day 7, restimulation with either
anti-CD3 and CD-28 or PdBu and ionomycin resulted in similar levels of interferon γ production in wild-type and
Mef2D knockout cells (Figure 2G).
Mef2D regulates IL-10 induction in BMDMs
Myeloid populations were similar between wild-type andMef2D knockout spleens, although, Mef2D knockout mice
did have a small increase in CD11b/Gr1 positive neutrophils in the spleen (Figure 3A,D). The numbers of CD11b /
F4/80 positive macrophages in the spleen were not significantly different between wild-type and Mef2D knockouts
(P>0.05, Student’s t-test, Figure 3B,D). There was a small decrease in the total number of CD11b/CD11c positive
cells, which would include CD8-ve classical dendritic cells. (Figure 3C,D). Overall, the above data indicate that loss of
Mef2D alone does not have a major impact on immune cell development.
Previous studies have found that Mef2D is expressed in human monocytes and is up-regulated as the cells differ-
entiate into macrophages [44]. We therefore looked at the effect of Mef2D knockout on macrophage function. Loss
of Mef2D did not block the M-CSF driven differentiation of bone marrow cell into macrophages in vitro (data not
shown). Analysis of mRNA levels for the different Mef2 isoforms showed that the wild type BMDMs expressed high
levels of bothMef2A andMef2D and low levels of Mef2C (Figure 4A). Mef2BmRNAwas not detected in the samples
(data not shown). Mef2 transcription factors have been linked to the regulation of several genes, including nur77
[21,45–48]. In BMDMs, nur77 mRNA was induced by the TLR4 agonist LPS (Figure 4B). Surprisingly, nur77 mRNA
induction was slightly increased in Mef2D knockout cells (Figure 4B). In contrast, the induction of two other imme-
diate early genes, egr1 and nurr1, in response to LPS was not affected by Mef2D knockout (Figure 4C,D), indicating
that any changes are restricted to a subset of genes and not a global up-regulation in the response. In addition toMef2,
CREB has also been found to regulate the nur77 promoter [41]. Downstream of LPS, CREB is phosphorylated by the
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 2. Mef2D is not required for T- or B-cell development
Thymi were isolated from wild-type and Mef2D knockout mice. Thymocytes were stained for Thy1, CD4 and CD8 and analysed
by flow cytometry. The numbers of thymocytes is shown in panel (A). Cells were gated on Thy1 expression and the percentage of
CD4 and CD8 positive cells is shown in panel (B), with quantification from four wild-type and 5 Mef2D knockout mice shown on
the left and representative plots on the right. In panels (C–E), spleens were isolated from nine wild-type and nine Mef2D knockout
mice and red blood cells lysed as described in the ‘Materials and Methods’ section and then cells stained for CD19, TCRβ, CD4
and CD8. Number of splenocytes is shown in panel (C). The percentage of T cells and B cells in the spleen is shown in panel (D).
The percentage of CD4 and CD8 cells in the T cell (TCRβ+ve) cells is shown in panel (E). In panels (F and G), CD8 T cells were
expanded from splenocytes ex vivo as described in the ‘Materials and Methods’ section. The number of cells present over time
in cultures from wild-type and Mef2D knockout mice is shown in (F). On day 7, cells were either left unstimulated or stimulated
with either anti-CD3 (1 μg/ml) and anti-CD28 (0.5 μg/ml) or PdBu (20 ng/ml) and ionomycin (0.5 μg/ml) for 4 h. Levels of interferon
γ secreted into the media were measured by ELISA panel (G). For panels (F and G), data show mean and standard deviation of
cultures from 4 mice per genotype. A P value of less than 0.05 (two-tailed Student’s t-test) is indicated by *.
6 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Mef2D is not essential for myeloid cell development
Spleens were isolated from five wild-type and four Mef2D knockout mice and red blood cells lysed as described in the ‘Materials
and Methods’ section and then cells stained for CD19, TCRβ and the indicated markers. Representative plots to identify CD11b
/ Gr1 positive neutrophils are shown in panel (A), CD11b / F4/80 positive macrophages in panel (B) and Cd11b / CD11c positive
conventional dendritic cells in panel (C). Average cell numbers and standard deviation for the three cell populations are shown in
panel (D). A P value of less than 0.05 (two-tailed Student’s t-test) is indicated by *.
kinasesMSK1 and 2 on Ser133 [40] and theMSK-dependent phosphorylation of CREB is required formaximal nur77
induction in fibroblasts and BMDMs [49,50]. We therefore looked at the effect of Mef2D knockout on CREB phos-
phorylation in response to LPS in BMDMs. The activation of MSK1, as judged by its phosphorylation on Ser376 or
the phosphorylation-induced band-shift in total MSK1 was also unaffected. In line with this CREB phosphorylation
was also unaffected (Figure 4E).
LPS stimulation of BMDMs results in the production of multiple pro-inflammatory cytokines, including TNF,
IL-6 and IL-12p40. Following 2 h of stimulation, wild-type and Mef2D BMDMs secreted similar amounts of TNF,
however from 4 to 12 h of stimulationMef2D knockouts secreted less TNF than wild-type cells (Figure 5A). A similar
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 4. Mef2D knockout does not inhibit TLR4 induced signalling in macrophages
(A) Bone marrow derived macrophages were isolated from wild-type and Mef2D knockout mice. The levels of Mef2A, Mef2C and
Mef2DmRNA relative to GAPDHmRNAwere then determined by qPCR. Error bars represent the standard deviation of independent
cultures from four mice per genotype. (B–E) BMDMs were stimulated with 100 ng/ml LPS for the indicated times. Total RNA was
isolated and the levels of nur77 (B), egr1 (C) and nurr1 (D) mRNA determined by qPCR. Fold change is expressed relative to the
level in unstimulated wild-type macrophages. Error bars represent standard deviation from independent cultures from three mice
per genotype. A P value (two-tailed Student’s t-test) between wild-type and Mef2D knockout cells of less than 0.001 is indicated by
** and less than 0.05 by *. (E) Cells were lysed and samples run on SDS poly-acrylamide gels and blotted for the indicated phospho
or total proteins (E). ns indicates a non-specific band detected by the phospho MSK1 antibody.
8 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. Mef2D knockout results in decreased pro-inflammatory production in LPS stimulated macrophages
Bone marrow derived macrophages were isolated from wild-type and Mef2D knockout mice. Cells were stimulated with 100 ng/ml
LPS for the indicated times. The levels of TNF (A), IL-6 (B) and IL-12p40 (C) secreted into the media are shown in panel (B). Total
RNA was isolated and the levels of TNF (D), IL-6 (E) and IL-12p40 (F) mRNA determined by qPCR. Values are expressed relative
to the level in unstimulated wild type macrophages (D–F). Error bars represent standard deviation from independent cultures from
three mice per genotype. A P value (two tailed Student’s t-test) between wild-type and Mef2D knockout cells of less than 0.001 is
indicated by ***, less than 0.01 by ** and less than 0.05 by *.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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pattern was also seen for IL-6 (Figure 5B) and IL-12p40 (Figure 5C). To determine if the changes in these cytokines
was also reflected at an mRNA level, qPCR was used to determine mRNA levels for these cytokines. As seen for
secreted protein, little difference between wild-type and Mef2D knockout BMDMs was observed for TNF, IL-6 and
IL-12p40 mRNA levels following 1 to 2 h of LPS stimulation (Figure 5D–F). However, from 4 h on lower levels of the
mRNA for these cytokines was observed inMef2D knockout BMDMs relative to wild-type cells, with this effect being
more pronounced for IL-6 and IL-12p40 than TNF (Figure 5D–F). The induction of pro-inflammatory cytokines
downstream of TLRs requires the activation of NFκB and MAPK signalling. The activation of ERK1/2 and p38α as
judged by phosphorylation on their TXY activation motifs was not affected by Mef2D knockout. NFκB is activated
by the IKK complex that phosphorylates both IκB and the p105 NFκB subunit. Mef2D knockout did not affect the
phosphorylation of p105 downstream of LPS activation, suggesting that NFκB activation was not blocked (Figure
4E).
In addition to stimulating the production of pro-inflammatory cytokines, LPS also stimulates the production of
the anti-inflammatory cytokine IL-10. Similar to nur77, IL-10 is another gene whose transcription has been linked to
both CREB and Mef transcription factors, the induction of IL-10 mRNA in response to LPS was determined. Mef2D
knockout BMDMs exhibited a higher induction of IL-10 mRNA in response to LPS than wild-type cells (Figure
6A). In line with the increased IL-10 mRNA levels, Mef2D knockout BMDMs also secreted higher levels of IL-10 in
response to LPS compared with wild-type cells (Figure 6B).
IL-10 is able to repress the production of TNF, IL-6 and IL-12p40 in response to LPS [40]. To determine if the
decreased production of pro-inflammatory cytokines in the Mef2D knockout BMDMs was due to their increased
production of IL-10 (Figure 5), the LPS stimulation was repeated in the presence or absence of an IL-10 neutralising
antibody. As observed in the previous experiment, LPS stimulated TNF, IL-6 and IL12p40 secretion in the absence
of the IL-10 antibody was lower in Mef2D knockouts relative to wild-type BMDMs (Figure 7A–C). Incubation of
the cells with the IL-10 neutralising antibody increased the LPS-stimulated production of TNF, IL-6 and IL-12p40 in
both wild-type and Mef2D knockout BMDMs compared to LPS stimulation in the absence of the IL-10 antibody. In
the presence of the IL-10 neutralising antibody, however, the levels of TNF, IL-6 and IL-12p40 were similar between
the wild-type and Mef2D knockout macrophages (Figure 7A–C). Analysis of mRNA induction showed that in the
presence of the neutralising antibody for IL-10, the levels of IL-6 and IL-12p40mRNA inductionwere similar between
wild-type andMef2D knockout cells, although a small decrease remained in the levels of TNFmRNA (Figure 7D–F).
Discussion
In the present study, we used Mef2D knockout mice to examine the potential role of Mef2D in T cells and
macrophages. The strategy we used to target Mef2D resulted in the removal of exons 2 and 3, which deleted the
coding sequence for amino acids 1 to 86. The next potential in frame ATG is at position 142, meaning any protein
would lack dimerization and DNA-binding domains critical for function. Three other Mef2D knockouts have been
reported. The first removed exon 3, and the resulting splicing from exon 2 to 4 resulted in an inactive Mef2D frag-
ment lacking amino acids 18 to 86 [27]. The other 2 knockouts removed exons 2 to 4 or 2 to 6 [28,29]. Similar to the
knockout reported here, all these lines were viable and fertile. Andzelm et al. and Omori et al. both reported issues
with the maintenance of photoreceptor cells in the retina [28,29], while Kim et al. reported protection to cardiac hy-
pertrophy and fibrosis in response to pressure overload and beta-chronic adrenergic stimulation in the heart [27],
none of which were addressed in the current study.
Mef2A and Mef2D have previously been reported to be active transcription factors in T cells and have been sug-
gested to regulate nur77 induction downstream of Ca2+ signalling [47]. Although Mef2D was strongly expressed in
the thymus, its loss did not appear to compromise T-cell development, as judged by normal numbers of T cells in
the thymus and spleen (Figure 2). Analysis of data in the ImmGen database confirmed that Mef2D was expressed
throughout T cell developmwnt with highest levels seen in DP cells in the thymus and lower levels seen in naive
CD4 and CD8 T cells in the spleen (Supplementary Figure S1). Among the other Mef2 isoforms, the expression of
Mef2A mirrored that of Mef2D. Mef2C was expressed in DN1 cells but was then down-regulated while Mef2B was
only expressed at very low levels. A recent proteomic study of T cells has also confirmed the expression of Mef2A and
Mef2D but not Mef2B or Mef2C in peripheral T cells [51]. Mef2A knockout mice exhibit a high degree of postnatal
mortality [26], however the effects of Mef2A knockout on T-cell development have not been reported. As discussed
further below, it is possible that Mef2A may compensate for the loss of Mef2D and that a double knockout may be
required to define the roles of these transcription factors in T cells.
Loss of Mef2D did also not prevent myeloid cell development, as indicated by the presence of neutrophils and
macrophages in the spleen. There was a small decrease in CD11b+ve/CD11c+ve cells in the spleen, a population that
10 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
D
ow
nloaded from
 https://portlandpress.com
/bioscirep/article-pdf/40/8/BSR
20201859/891358/bsr-2020-1859.pdf by U
K user on 26 August 2020
Bioscience Reports (2020) 40 BSR20201859
https://doi.org/10.1042/BSR20201859
Figure 6. Mef2D acts as a negative regulator of LPS induced IL-10 production
Bone marrow derived macrophages were isolated from wild type and Mef2D knockout mice. Cells were stimulated with 100 ng/ml
LPS for the indicated times. Total RNA was isolated and the levels of IL-10 mRNA determined by qPCR. Values are expressed
relative to the level in unstimulated wild type macrophages (A). The levels of IL-10 secreted into the media are shown in (B). Error
bars represent standard deviation from independent cultures from 3 mice per genotype. A p value (2 tailed Students ttest) between
wild type and knockout cells of less than 0.001 is indicated by *** and less than 0.05 by *.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 7. Decreased LPS induced pro-inflammatory cytokine production in Mef2D knockout macrophages is dependent on
IL-10
Bone marrow derived macrophages were isolated from wild-type and Mef2D knockout mice. Cells were stimulated with 100 ng/ml
LPS for 8 h in the presence or absence of a neutralising antibody against IL-10. The levels of TNF (A), IL-6 (B) and IL-12p40 (C)
secreted into the media are shown in panel (B). Total RNA was isolated and the levels of TNF (D), IL-6 (E) and IL-12p40 (F) mRNA
determined by qPCR. Values are expressed relative to the level in unstimulated wild-type macrophages (D–F). Error bars represent
standard deviation from independent cultures from three mice per genotype. A P value (Student’s t-test) between wild-type and
knockout cells of less than 0.001 is indicated by ***, less than 0.01 by ** and less than 0.05 by *.
would include the CD8-ve subset of classical dendritic cells. A detailed analysis of myeloid developmental precursors
or dendritic cells was not carried out and it is possible that Mef2D knockout would have effects in these processes.
Macrophages were also found to expressMef2A andD, however unlike T cells they also expressedMef2C.We show
here that in bone marrow derived macrophages, loss of Mef2D results in an elevated production of IL-10 in response
to LPS compared with wild-type cells. As a result of this increased IL-10 production, Mef2D knockout macrophages
secreted lower levels of TNF, IL6 and IL-12p40. Previous studies have identified a potential Mef2-binding site in
the IL-10 promoter and shown that overexpression of Mef2D increased IL-10 promoter activity in human T cells
[52,53]. shRNA-mediated knockdown of Mef2D in the BV2 microglial cell line also reduced IL-10 induction [54]. In
contrast, BMDMs IL-10 production was higher in Mef2D knockouts than wild-type cells (Figure 5). Furthermore,
12 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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there was a slight increase in the induction of the Mef2 target gene nur77. One potential explanation for this could
be compensation between Mef2 isoforms. In addition to Mef2D, bone marrow derived macrophages also express
Mef2A and Mef2C. It is possible that the increased transcription of IL-10 in the Mef2D knockout may result from
the replacement of Mef2D on the IL-10 promoter with a different Mef2 isoform, which may have a higher ability
to activate the IL-10 promoter. Of note, it has been demonstrated that deletion of Mef2D in granule neurons in the
cerebellum results in the recruitment ofMef2A to a subset of promoters normally bound byMef2D [55]. Redundancy
between Mef2 isoforms is also established in the literature. Partial redundancy between Mef2C and Mef2D has been
reported in B-cell development. Redundancy of Mef2A, Mef2C and Mef2D has been observed in the CNS; brain
specific Mef2A/D double knockouts are viable whereas brain specific deletion of Mef2A, C and D results in postnatal
mortality and neuronal apoptosis [22]. Combined deletion ofMef2A, C andD is also required to block skeletalmuscle
regeneration with single knockouts having no impact [30]. A further question is how Mef2 transcription factors are
regulated in macrophages. Mef2 isoforms have been reported to be MAPK substrates in other systems [13]. TLRs are
known to activatemultipleMAPKpathways inmacrophages and it would therefore be possible thatMef2 is controlled
by MAPKs in response to TLR stimulation; however, further studies would be required to establish this.
In conclusion, we show here that Mef2D plays a role in the regulation of the important anti-inflammatory cytokine
IL-10 in macrophages. Further studies will however be required to address functional compensation between Mef2
isoforms in macrophages.
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